loxoprofen has been researched along with Odontalgia in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nanoemulsions (NEs) are one type of delivery system that helps to improve the solubility and dissolution of drugs, attempting to enhance their bioavailability and onset of action." | 1.62 | Development of omega-3 loxoprofen-loaded nanoemulsion to limit the side effect associated with NSAIDs in treatment of tooth pain. ( Abualsunun, WA; Alhakamy, NA; Alkhalidi, HM; Almehmady, AM; Alruwaili, NK; Bakhaidar, RB; Hassan, AH; Hosny, KM; Khallaf, RA; Khames, A; Kurakula, M; Rizg, WY; Sindi, AM, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosny, KM | 1 |
| Sindi, AM | 1 |
| Alkhalidi, HM | 1 |
| Kurakula, M | 1 |
| Hassan, AH | 1 |
| Bakhaidar, RB | 1 |
| Abualsunun, WA | 1 |
| Almehmady, AM | 1 |
| Khames, A | 1 |
| Rizg, WY | 1 |
| Khallaf, RA | 1 |
| Alruwaili, NK | 1 |
| Alhakamy, NA | 1 |
1 other study available for loxoprofen and Odontalgia
| Article | Year |
|---|---|
Development of omega-3 loxoprofen-loaded nanoemulsion to limit the side effect associated with NSAIDs in treatment of tooth pain.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical | 2021 |